Eupraxia Pharmaceuticals Stock Forecast - Day Median Price
| EPRX Stock | CAD 8.13 0.20 2.40% |
Eupraxia Stock Forecast is based on your current time horizon. Although Eupraxia Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Eupraxia Pharmaceuticals' systematic risk associated with finding meaningful patterns of Eupraxia Pharmaceuticals fundamentals over time.
Eupraxia |
| Previous Day Median Price | Day Median Price | Trend |
| 8.37 | 8.37 |
| Check Eupraxia Pharmaceuticals Volatility | Backtest Eupraxia Pharmaceuticals | Information Ratio |
Eupraxia Pharmaceuticals Trading Date Momentum
| On October 06 2025 Eupraxia Pharmaceuticals was traded for 8.13 at the closing time. The highest price during the trading period was 8.62 and the lowest recorded bid was listed for 8.12 . There was no trading activity during the period 0.0. Lack of trading volume on October 6, 2025 did not affect price variability. The overall trading delta to the current price is 3.32% . |
The median price is the midpoint of the trading periods range.
| Compare Eupraxia Pharmaceuticals to competition |
Other Forecasting Options for Eupraxia Pharmaceuticals
For every potential investor in Eupraxia, whether a beginner or expert, Eupraxia Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eupraxia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eupraxia. Basic forecasting techniques help filter out the noise by identifying Eupraxia Pharmaceuticals' price trends.Eupraxia Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eupraxia Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Eupraxia Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eupraxia Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eupraxia Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Eupraxia Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Eupraxia Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eupraxia Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Eupraxia Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eupraxia Pharmaceuticals stock market strength indicators, traders can identify Eupraxia Pharmaceuticals entry and exit signals to maximize returns.
Eupraxia Pharmaceuticals Risk Indicators
The analysis of Eupraxia Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eupraxia Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eupraxia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.27 | |||
| Semi Deviation | 2.62 | |||
| Standard Deviation | 3.16 | |||
| Variance | 10.02 | |||
| Downside Variance | 8.51 | |||
| Semi Variance | 6.86 | |||
| Expected Short fall | (2.60) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Eupraxia Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eupraxia Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Eupraxia Stock
Moving against Eupraxia Stock
The ability to find closely correlated positions to Eupraxia Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eupraxia Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eupraxia Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eupraxia Pharmaceuticals to buy it.
The correlation of Eupraxia Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eupraxia Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eupraxia Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eupraxia Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Eupraxia Stock
Eupraxia Pharmaceuticals financial ratios help investors to determine whether Eupraxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eupraxia with respect to the benefits of owning Eupraxia Pharmaceuticals security.